Emerging therapeutic strategies for Wnt-dependent colon cancer targeting macropinocytosis

  • 0Department of Oncology Science, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

|

|

Summary

This summary is machine-generated.

Aberrations in Wnt signaling drive colorectal cancer (CRC). Targeting membrane trafficking, including macropinocytosis, offers a novel therapeutic strategy for CRC treatment.

Area Of Science

  • Oncology
  • Cell Biology
  • Molecular Biology

Background

  • Wnt signaling pathway aberrations, including APC and β-catenin mutations, are key drivers of colorectal cancer (CRC) initiation and progression.
  • Membrane trafficking regulates Wnt signaling by controlling the activation, modulation, and secretion of signaling molecules crucial for CRC development.

Purpose Of The Study

  • To explore the intricate connection between membrane trafficking and Wnt signaling in colorectal cancer.
  • To specifically investigate the role of macropinocytosis in Wnt signal regulation within the context of CRC.

Main Methods

  • Literature review focusing on the interplay between Wnt signaling and membrane trafficking pathways.
  • Analysis of macropinocytosis as a regulatory mechanism within the Wnt pathway.
  • Examination of therapeutic strategies targeting these pathways.

Main Results

  • Wnt signaling and macropinocytosis are critically linked, playing roles in both embryonic development and cancer onset.
  • Membrane trafficking processes, particularly macropinocytosis, are integral to Wnt signal regulation in CRC.
  • Targeting Wnt signaling via modulation of macropinocytosis and membrane trafficking is a promising therapeutic avenue.

Conclusions

  • The convergence of Wnt signaling and membrane trafficking, especially macropinocytosis, presents a novel therapeutic dimension for colorectal cancer.
  • Emerging therapeutic strategies targeting these pathways are advancing, with several candidates in early clinical trials.
  • Modulating Wnt signaling and associated membrane trafficking offers a promising strategy for innovative CRC treatments.

Related Concept Videos

Targeted Cancer Therapies 02:57

7.5K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Canonical Wnt Signaling Pathway 02:54

8.7K

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

Non-Canonical Wnt Signaling Pathways 01:41

7.2K

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...

Cancer Cell Migration through Invadopodia 01:35

2.3K

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...